(Q45862734)

17 December 2017

title

Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes (English)

1 reference

17 December 2017

author name string

Peter Meyerhuber

1

1 reference

17 December 2017

Heinke Conrad

2

1 reference

17 December 2017

Lilian Stärck

3

1 reference

17 December 2017

Matthias Leisegang

4

1 reference

17 December 2017

Dirk H Busch

5

1 reference

17 December 2017

Wolfgang Uckert

6

1 reference

17 December 2017

Helga Bernhard

7

1 reference

17 December 2017

publication date

11 August 2010

1 reference

17 December 2017

Journal of Molecular Medicine

published in

1 reference

17 December 2017

volume

88

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

1113-1121

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s00109-010-0660-z

exact match

0 references

cites work

CTLs directed against HER2 specifically cross-react with HER3 and HER4.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-010-0660-Z

Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-010-0660-Z

Tumour immunity: effector response to tumour and role of the microenvironment

21 January 2018

1 reference

12 December 2020

Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.

1 reference

12 December 2020

Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes

1 reference

12 December 2020

Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice

1 reference

12 December 2020

Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells

1 reference

12 December 2020

Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette

1 reference

12 December 2020

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

12 December 2020

Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients

1 reference

12 December 2020

HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes

1 reference

12 December 2020

The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia

1 reference

12 December 2020

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

1 reference

12 December 2020

Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals

1 reference

12 December 2020

Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.

1 reference

12 December 2020

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells

1 reference

12 December 2020

Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity

1 reference

12 December 2020

Immunoediting sculpts tumor epitopes during immunotherapy

1 reference

12 December 2020

Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells

1 reference

12 December 2020

Facilitating matched pairing and expression of TCR chains introduced into human T cells

1 reference

12 December 2020

Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine

1 reference

12 December 2020

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

1 reference

12 December 2020

Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas

1 reference

12 December 2020

Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches

1 reference

12 December 2020

Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases

1 reference

12 December 2020

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.

1 reference

12 December 2020

TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008.

1 reference

12 December 2020

Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.

1 reference

12 December 2020

Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype

1 reference

12 December 2020

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

1 reference

12 December 2020

Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression

1 reference

12 December 2020

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

1 reference

12 December 2020

T-cell-receptor gene therapy

1 reference

12 December 2020

Retroviral vectors for high-level transgene expression in T lymphocytes

1 reference

12 December 2020

10.1007/S00109-010-0660-Z

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1034351958

0 references

1 reference

17 December 2017